Skip to main content
Top
Published in: Lasers in Medical Science 3/2022

Open Access 01-04-2022 | CO2 Laser | Original Article

CO2 laser colposcopic guided surgery for the see and treat management of VHSIL: a preliminary experience

Authors: C. Bianchi, N. Auzzi, I. Turrini, A. De Magnis, M. G. Fallani, M. Fambrini, A. Pieralli

Published in: Lasers in Medical Science | Issue 3/2022

Login to get access

Abstract

The purpose of this study is to evaluate the efficiency of CO2 laser colposcopic guided surgery performed in an outpatient see and treat setting in the management of VHSIL. Women with a suspected diagnosis of VHSIL and no vulvoscopic suspicion of vSCC were enrolled. An electronic register of CO2 laser treatment was created where description of performing parameters (excision or ablation) was specified and personal history was recorded. Statistical analysis was performed by Fisher’s exact test. Relative risks (RR) of risk factor were calculated and expressed in odds. From September 2014 to September 2018, we enrolled a total of 63 patients who underwent CO2 laser procedure and had a minimum follow-up time of 2 years at Careggi University Hospital in Florence. Forty-eight (76.2%) patients underwent laser excision and 15 (23.8%) patients underwent ablative treatment without histological results. Undertreatment was performed in 3 cases (6.3%) with definitive histology of vSCC. Therapeutical appropriateness of CO2 laser excision was reached in 85.4% of the cases (41/48). No volunteer loss to follow-up was registered; thus, fidelity to treatment was assess at 100%. Recurrence rate within 2 years attested in 8/60 followed patients (13.3%). No personal factor was found to influence the VHSIL course. CO2 laser excision may represent an excellent therapeutic option to VHSIL because it provides adequate oncological purpose with good cosmetic and functional results and high patients’ loyalty to treatment. An expert team could allow to undergo patients with VHSIL suspicion to unique diagnostic and therapeutic procedure with significant benefits.
Literature
2.
go back to reference Østergård S, Vorbeck CS, Meinert M (2018) Vulvar intraepithelial neoplasia. Ugeskr Laeger 180(20): 2–5. V12170931PubMed Østergård S, Vorbeck CS, Meinert M (2018) Vulvar intraepithelial neoplasia. Ugeskr Laeger 180(20): 2–5. V12170931PubMed
6.
go back to reference (2016) Committee Opinion No.675: Management of vulvar intraepithelial neoplasia. American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice; American Society for Colposcopy and Cervical Pathology (ASCCP). Obstet Gynecol 128(4):178–182. https://doi.org/10.1097/AOG.0000000000001713 (2016) Committee Opinion No.675: Management of vulvar intraepithelial neoplasia. American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice; American Society for Colposcopy and Cervical Pathology (ASCCP). Obstet Gynecol 128(4):178–182. https://​doi.​org/​10.​1097/​AOG.​0000000000001713​
9.
go back to reference Tristram A, Hurt CN, Madden T, Powell N, Man S, Hibbitts S, Dutton P, Jones S, Nordin AJ, Naik R, Fiander A, Griffiths G (2014) Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 15(12):1361–1368. https://doi.org/10.1016/S1470-2045(14)70456-5CrossRefPubMed Tristram A, Hurt CN, Madden T, Powell N, Man S, Hibbitts S, Dutton P, Jones S, Nordin AJ, Naik R, Fiander A, Griffiths G (2014) Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 15(12):1361–1368. https://​doi.​org/​10.​1016/​S1470-2045(14)70456-5CrossRefPubMed
14.
go back to reference Penna C, Fallani MG, Fambrini M, Zipoli E, Marchionni M (2002) CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques. J Reprod Med 47(11):913–918PubMed Penna C, Fallani MG, Fambrini M, Zipoli E, Marchionni M (2002) CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques. J Reprod Med 47(11):913–918PubMed
15.
go back to reference Hoffman MS, Pinelli DM, Finan M, Roberts WS, Fiorica JV, Cavanagh D (1992) Laser vaporization for vulvar intraepithelial neoplasia III. J Reprod Med 37(2):135–137PubMed Hoffman MS, Pinelli DM, Finan M, Roberts WS, Fiorica JV, Cavanagh D (1992) Laser vaporization for vulvar intraepithelial neoplasia III. J Reprod Med 37(2):135–137PubMed
16.
go back to reference Küppers V, Stiller M, Somville T, Bender HG (1997) Risk factors for recurrent VIN. Role of multifocality and grade of disease. J Reprod Med 42(3):140–144PubMed Küppers V, Stiller M, Somville T, Bender HG (1997) Risk factors for recurrent VIN. Role of multifocality and grade of disease. J Reprod Med 42(3):140–144PubMed
Metadata
Title
CO2 laser colposcopic guided surgery for the see and treat management of VHSIL: a preliminary experience
Authors
C. Bianchi
N. Auzzi
I. Turrini
A. De Magnis
M. G. Fallani
M. Fambrini
A. Pieralli
Publication date
01-04-2022
Publisher
Springer London
Keywords
CO2 Laser
Laser
Published in
Lasers in Medical Science / Issue 3/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-021-03413-y

Other articles of this Issue 3/2022

Lasers in Medical Science 3/2022 Go to the issue